90-Day Mortality Rate In Cancer Patients Treated Within The Context Of Phase I Trials: Can We Identify Patients Who Should Not Go On Trial?

J Ang,H Arkenau,David Olmos,J Barriuso, S Ashley, Alan D Little,Simon Pacey,J S De Bono, I Judson,S B Kaye

JOURNAL OF CLINICAL ONCOLOGY（2008）

引用 1|浏览10

暂无评分

摘要

2510 Background: Phase I trials are crucial for the development of new anticancer therapies. Common inclusion criteria for phase I trials include “life expectancy > 3 months”; however, many recentl...

查看译文

关键词

cancer patients,trials,mortality,trials

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要